• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Immunoassay Analyzers Market

    ID: MRFR/MED/17846-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    US Immunoassay Analyzers Market Research Report: By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), By Application (Infectious Diseases, Autoimmune Diseases, AIDS) and By End User (Hospitals) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Immunoassay Analyzers Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    US Immunoassay Analyzers Market Summary

    The US Immunoassay Analyzers market is projected to grow significantly from 299.6 million USD in 2024 to 614.0 million USD by 2035.

    Key Market Trends & Highlights

    US Immunoassay Analyzers Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate of 6.74 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 614.0 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 299.6 million USD, reflecting a solid foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing healthcare demands is a major market driver.

    Market Size & Forecast

    2024 Market Size 299.6 (USD Million)
    2035 Market Size 614.0 (USD Million)
    CAGR (2025-2035) 6.74%

    Major Players

    Quidel Corporation, Siemens Healthineers, Genzyme, Roche Diagnostics, BioRad Laboratories, Medtronic, Fujirebio, Thermo Fisher Scientific, Olympus Corporation, Hologic, Ortho Clinical Diagnostics, Abbott Laboratories, Laboratory Corporation of America, Agilent Technologies, Beckman Coulter

    US Immunoassay Analyzers Market Trends

    In the US Immunoassay Analyzers Market, a significant trend is the increasing adoption of point-of-care (POC) testing, which facilitates quicker diagnosis and treatment. This trend is driven by the demand for faster results, particularly in emergency and outpatient settings, enhancing patient care. Another key market driver is the rise in chronic diseases and infectious diseases, leading to higher testing volumes. The US healthcare system is focusing on improving diagnostic capabilities, thereby promoting the installation of advanced immunoassay analyzers in laboratories and healthcare facilities.

    Furthermore, the push for automation in laboratories represents another strong trend, as it minimizes human error and increases throughput.Opportunities in the US market include the development of more sensitive and specific testing assays, which can detect diseases at earlier stages. There is also potential for innovation in portable and compact analyzers which can be utilized in smaller clinics or home testing scenarios.

    Investments in research and development from both public and private sectors are encouraging advancements in this field. The regulatory environment in the US, particularly under agencies such as the FDA, facilitates the approval process for novel diagnostic technologies, further enabling market growth. Recent trends indicate increased integration of digital technologies into immunoassay analyzers, enhancing data management and connectivity for better decision-making in clinical settings.The trend towards personalized medicine is also prominent, as clinicians seek tailored treatments based on individual patient profiles.

    Overall, the US Immunoassay Analyzers Market is evolving rapidly, with current innovations and a proactive regulatory landscape encouraging a diversified range of products and technologies.

    US Immunoassay Analyzers Market Drivers

    Market Segment Insights

    Immunoassay Analyzers Market Instruments Insights

    The Instruments segment of the US Immunoassay Analyzers Market has witnessed robust growth and adaption, driven by the rise in demand for accurate and efficient diagnostic solutions. This segment is fundamental to the US healthcare industry, providing essential tools for disease prevention, diagnostics, and treatment monitoring. The segment comprises various methodologies with unique applications and technologies, such as Immunofluorescence, Chemiluminescence, Enzyme-Linked Immunosorbent Assay (ELISA), and Radioimmunoassay.

    Immunofluorescence, known for its remarkable sensitivity and specificity, plays a pivotal role in detecting specific antigens and antibodies in samples, making it indispensable in research and clinical diagnostics, particularly in autoimmune disorders and infectious diseases. Chemiluminescence, esteemed for its high-throughput capabilities and enhanced detection limits, is increasingly preferred in laboratories aiming to process large volumes of samples for various biomarkers efficiently. ELISA remains a gold standard in immunoassays, favored for its versatility and robustness in quantifying proteins, hormones, and antibodies across numerous applications, particularly in the fields of immunology and food safety testing.

    Radioimmunoassay, while less commonly used today compared to other techniques due to safety concerns, still finds its niche in specific applications due to its sensitivity and ability to detect low concentrations of antigens.As the healthcare landscape evolves, the demand for more precise, rapid, and efficient diagnostic tools continues to fuel growth in the Instruments segment. Streamlined workflows and technological advancements are driving innovation and improvements in performance, making it imperative for laboratories to integrate such instruments for competitive advantages.

    Additionally, the aging population and the rise in chronic diseases in the US further escalate the need for effective diagnostic solutions, thereby enhancing market growth prospects. 

    The strategic importance of this segment is underscored by its contribution to research and development initiatives aimed at improving diagnostic accuracy and efficacy, fostering collaborations and investments among industry stakeholders for enhanced product offerings tailored to meet the diverse needs of the healthcare industry. Overall, the Instruments segment holds a significant position within the US Immunoassay Analyzers Market, demonstrating strong potential for future growth amidst evolving healthcare demands and technological advancements.

    Immunoassay Analyzers Market Application Insights

    The Application segment of the US Immunoassay Analyzers Market showcases significant importance, intersecting various crucial healthcare areas. This segment primarily focuses on areas like Infectious Diseases, Autoimmune Diseases, and AIDS, reflecting the market's adaptability towards conditions that require accurate diagnostics. Infectious Diseases are a leading application, driven by the ongoing need for rapid and precise testing in managing outbreaks, a demand amplified by health crises such as the COVID-19 pandemic.

    Autoimmune Diseases Treatment represent another vital area, as the rising prevalence necessitates advanced diagnostic tools for effective treatment, supporting patient outcomes through timely interventions.AIDS continues to be a major focus as well, emphasizing the importance of early detection and ongoing monitoring to enhance patient survival rates. The interplay of these applications not only highlights the growth potential of the US Immunoassay Analyzers Market but also underscores the urgent need for innovative and reliable diagnostic solutions in the face of evolving healthcare challenges.

    This positioning within essential health needs illustrates the increasing reliance on immunoassay technologies, driving the market dynamic towards sustained growth and development.

    Immunoassay Analyzers Market End User Insights

    The Hospitals segment plays a critical role in the US Immunoassay Analyzers Market, as these institutions are primary users of diagnostic testing technologies. Hospitals utilize immunoassay analyzers for a variety of applications, including disease screening and monitoring, which enhances patient care and treatment decisions. The rising prevalence of chronic diseases in the United States has driven demand for accurate and rapid diagnostic solutions in hospital settings.

    Furthermore, advancements in technology, such as the integration of automated systems for immunoassays, have significantly improved operational efficiency in hospitals.Hospitals are often equipped with the latest technology to ensure timely and reliable results, making them a dominant force within the overall market landscape. This segment benefits from ongoing investments in healthcare infrastructure and an increasing focus on improving patient outcomes, which are supported by government initiatives and funding. As a result, hospitals continue to expand their capabilities in immunodiagnostics, supporting the growth of the US Immunoassay Analyzers Market.

    Get more detailed insights about US Immunoassay Analyzers Market

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The US Immunoassay Analyzers Market is characterized by rapid technological advancements and a dynamic competitive landscape. This market provides diagnostic solutions essential to identifying various health conditions, making it crucial for both clinical and research laboratories. Companies in this sector are continually innovating to enhance the precision and efficiency of their analyzers, leading to an increase in demand for more advanced systems. Competitive strategies in this market typically involve extensive research and development efforts, focused marketing initiatives, and collaborative partnerships between manufacturers and healthcare providers.

    Understanding the competitive landscape is imperative for organizations looking to establish or enhance their presence in the US Immunoassay Analyzers Market.

    Quidel Corporation presents a robust competitive presence in the US Immunoassay Analyzers Market, recognized for its commitment to innovation in diagnostic solutions. The company has made significant strides in developing a variety of immunoassay technologies that cater to diverse clinical needs, particularly in point-of-care testing. This focus on accessible diagnostic tools positions Quidel Corporation favorably within the competitive landscape. Its operational efficiencies, supply chain management, and customer service capabilities further strengthen its market position.

    With a reputation for delivering reliable and accurate results, Quidel Corporation has established strong relationships with healthcare providers and laboratory professionals, enhancing customer loyalty and fostering repeat business.

    Siemens Healthineers stands out prominently in the US Immunoassay Analyzers Market, known for its extensive portfolio of advanced diagnostic solutions. The company offers a broad range of immunoassay analyzers designed for high-throughput settings and point-of-care environments, addressing varying clinical diagnostics requirements. Siemens Healthineers has a strategic focus on delivering cutting-edge technology that promotes efficiency and accuracy in laboratory testing. With a strong market presence, the company emphasizes a culture of continuous innovation, often investing in research and development to improve its products.

    Siemens Healthineers has also engaged in various mergers and acquisitions to enhance its technological capabilities and expand its market share within the US. These strategic moves not only bolster its competitive edge but also enable the company to offer integrated solutions to healthcare providers, fulfilling a wide array of diagnostic needs in the immunoassay domain.

    Key Companies in the US Immunoassay Analyzers Market market include

    Industry Developments

    Recent developments in the US Immunoassay Analyzers Market have seen significant activity among key players such as Quidel Corporation, Siemens Healthineers, and Roche Diagnostics. In October 2023, Quidel Corporation announced the release of a new diagnostic test that enhances the accuracy of immunoassay analyses, positioning the company for increased market share. Siemens Healthineers has also recently expanded its portfolio with advanced immunoassay analyzers that improve test turnaround time. Furthermore, in September 2023, Roche Diagnostics entered into a strategic partnership with Hologic to collaborate on the development of next-generation immunoassay technologies.

    On the mergers and acquisitions front, in August 2023, Thermo Fisher Scientific acquired a leading competitor in the immunoassay space, further consolidating its market presence. Over the past two to three years, there has been a noticeable growth in the market valuation of companies like Abbott Laboratories and BioRad Laboratories, driven by increased demand for rapid testing solutions, especially amid the ongoing changes in healthcare dynamics. This growth trend reflects an overarching shift toward personalized medicine and improved diagnostics in the US healthcare system, supported by governmental initiatives aimed at enhancing laboratory capabilities.

    Market Segmentation

    Immunoassay Analyzers Market End User Outlook

    • Hospitals

    Immunoassay Analyzers Market Application Outlook

    • Infectious Diseases
    • Autoimmune Diseases
    • AIDS

    Immunoassay Analyzers Market Instruments Outlook

    • Immunofluorescence
    • Chemiluminescence
    • ELISA
    • Radioimmunoassay

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 284.05(USD Million)
    MARKET SIZE 2024 299.65(USD Million)
    MARKET SIZE 2035 614.02(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.739% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Quidel Corporation, Siemens Healthineers, Genzyme, Roche Diagnostics, BioRad Laboratories, Medtronic, Fujirebio, Thermo Fisher Scientific, Olympus Corporation, Hologic, Ortho Clinical Diagnostics, Abbott Laboratories, Laboratory Corporation of America, Agilent Technologies, Beckman Coulter
    SEGMENTS COVERED Instruments, Application, End User
    KEY MARKET OPPORTUNITIES Increased point-of-care testing, Rising demand for personalized medicine, Advancements in automation technology, Growing prevalence of chronic diseases, Expansion of healthcare facilities.
    KEY MARKET DYNAMICS Growing demand for rapid diagnostics, Increasing prevalence of chronic diseases, Technological advancements in analyzer systems, Rising focus on personalized medicine, Expanding healthcare infrastructure
    COUNTRIES COVERED US

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the US Immunoassay Analyzers Market in 2024?

    The US Immunoassay Analyzers Market is expected to be valued at 299.65 USD Million in 2024.

    What will be the market value of the US Immunoassay Analyzers Market by 2035?

    By 2035, the market is projected to reach a value of 614.02 USD Million.

    What is the expected CAGR for the US Immunoassay Analyzers Market from 2025 to 2035?

    The anticipated compound annual growth rate for the market from 2025 to 2035 is 6.739%.

    Which segment is valued the highest in the US Immunoassay Analyzers Market in 2024?

    In 2024, the Chemiluminescence segment is anticipated to have the highest value at 120.0 USD Million.

    What will be the market value for Immunofluorescence in 2035?

    The market value for Immunofluorescence is expected to reach 160.0 USD Million by 2035.

    What are the key players dominating the US Immunoassay Analyzers Market?

    Major players in the market include Quidel Corporation, Siemens Healthineers, Roche Diagnostics, and Abbott Laboratories.

    How is the Radioimmunoassay segment projected to perform by 2035?

    The Radioimmunoassay segment is projected to grow to a value of 74.02 USD Million by 2035.

    What is the projected market size for the ELISA segment in 2024?

    In 2024, the ELISA segment is expected to be valued at 65.0 USD Million.

    What are the growth drivers anticipated for the US Immunoassay Analyzers Market?

    Key growth drivers include increasing demand for diagnostic testing and advancements in technology in immunoassay analyzers.

    What challenges does the US Immunoassay Analyzers Market face?

    Challenges include regulatory hurdles and intense competition among key players in the market.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. US Immunoassay Analyzers Market, BY Instruments (USD Million)
    45. Immunofluorescence
    46. Chemiluminescence
    47. ELISA
    48. Radioimmunoassay
    49. US Immunoassay Analyzers Market, BY Application (USD Million)
    50. Infectious Diseases
    51. Autoimmune Diseases
    52. AIDS
    53. US Immunoassay Analyzers Market, BY End User (USD Million)
    54. Hospitals
    55. Competitive Landscape
    56. Overview
    57. Competitive Analysis
    58. Market share Analysis
    59. Major Growth Strategy in the Immunoassay Analyzers Market
    60. Competitive Benchmarking
    61. Leading Players in Terms of Number of Developments in the Immunoassay Analyzers Market
    62. Key developments and growth strategies
    63. New Product Launch/Service Deployment
    64. Merger & Acquisitions
    65. Joint Ventures
    66. Major Players Financial Matrix
    67. Sales and Operating Income
    68. Major Players R&D Expenditure. 2023
    69. Company Profiles
    70. Quidel Corporation
    71. Financial Overview
    72. Products Offered
    73. Key Developments
    74. SWOT Analysis
    75. Key Strategies
    76. Siemens Healthineers
    77. Financial Overview
    78. Products Offered
    79. Key Developments
    80. SWOT Analysis
    81. Key Strategies
    82. Genzyme
    83. Financial Overview
    84. Products Offered
    85. Key Developments
    86. SWOT Analysis
    87. Key Strategies
    88. Roche Diagnostics
    89. Financial Overview
    90. Products Offered
    91. Key Developments
    92. SWOT Analysis
    93. Key Strategies
    94. BioRad Laboratories
    95. Financial Overview
    96. Products Offered
    97. Key Developments
    98. SWOT Analysis
    99. Key Strategies
    100. Medtronic
    101. Financial Overview
    102. Products Offered
    103. Key Developments
    104. SWOT Analysis
    105. Key Strategies
    106. Fujirebio
    107. Financial Overview
    108. Products Offered
    109. Key Developments
    110. SWOT Analysis
    111. Key Strategies
    112. Thermo Fisher Scientific
    113. Financial Overview
    114. Products Offered
    115. Key Developments
    116. SWOT Analysis
    117. Key Strategies
    118. Olympus Corporation
    119. Financial Overview
    120. Products Offered
    121. Key Developments
    122. SWOT Analysis
    123. Key Strategies
    124. Hologic
    125. Financial Overview
    126. Products Offered
    127. Key Developments
    128. SWOT Analysis
    129. Key Strategies
    130. Ortho Clinical Diagnostics
    131. Financial Overview
    132. Products Offered
    133. Key Developments
    134. SWOT Analysis
    135. Key Strategies
    136. Abbott Laboratories
    137. Financial Overview
    138. Products Offered
    139. Key Developments
    140. SWOT Analysis
    141. Key Strategies
    142. Laboratory Corporation of America
    143. Financial Overview
    144. Products Offered
    145. Key Developments
    146. SWOT Analysis
    147. Key Strategies
    148. Agilent Technologies
    149. Financial Overview
    150. Products Offered
    151. Key Developments
    152. SWOT Analysis
    153. Key Strategies
    154. Beckman Coulter
    155. Financial Overview
    156. Products Offered
    157. Key Developments
    158. SWOT Analysis
    159. Key Strategies
    160. References
    161. Related Reports
    162. US Immunoassay Analyzers Market SIZE ESTIMATES & FORECAST, BY INSTRUMENTS, 2019-2035 (USD Billions)
    163. US Immunoassay Analyzers Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    164. US Immunoassay Analyzers Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    165. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    166. ACQUISITION/PARTNERSHIP
    167. MARKET SYNOPSIS
    168. US IMMUNOASSAY ANALYZERS MARKET ANALYSIS BY INSTRUMENTS
    169. US IMMUNOASSAY ANALYZERS MARKET ANALYSIS BY APPLICATION
    170. US IMMUNOASSAY ANALYZERS MARKET ANALYSIS BY END USER
    171. KEY BUYING CRITERIA OF IMMUNOASSAY ANALYZERS MARKET
    172. RESEARCH PROCESS OF MRFR
    173. DRO ANALYSIS OF IMMUNOASSAY ANALYZERS MARKET
    174. DRIVERS IMPACT ANALYSIS: IMMUNOASSAY ANALYZERS MARKET
    175. RESTRAINTS IMPACT ANALYSIS: IMMUNOASSAY ANALYZERS MARKET
    176. SUPPLY / VALUE CHAIN: IMMUNOASSAY ANALYZERS MARKET
    177. IMMUNOASSAY ANALYZERS MARKET, BY INSTRUMENTS, 2025 (% SHARE)
    178. IMMUNOASSAY ANALYZERS MARKET, BY INSTRUMENTS, 2019 TO 2035 (USD Billions)
    179. IMMUNOASSAY ANALYZERS MARKET, BY APPLICATION, 2025 (% SHARE)
    180. IMMUNOASSAY ANALYZERS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    181. IMMUNOASSAY ANALYZERS MARKET, BY END USER, 2025 (% SHARE)
    182. IMMUNOASSAY ANALYZERS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    183. BENCHMARKING OF MAJOR COMPETITORS

    US Immunoassay Analyzers Market Segmentation

    • Immunoassay Analyzers Market By Instruments (USD Million, 2019-2035)

      • Immunofluorescence
      • Chemiluminescence
      • ELISA
      • Radioimmunoassay

    • Immunoassay Analyzers Market By Application (USD Million, 2019-2035)

      • Infectious Diseases
      • Autoimmune Diseases
      • AIDS

    • Immunoassay Analyzers Market By End User (USD Million, 2019-2035)

      • Hospitals
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027